During the past decade, Heart Health Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart Health Institute" #1 sponsor was "University of Washington" with 2 trials, followed by "Axio Research. LLC" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "Sanofi" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Health Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Heart Health Institute" are "Atherosclerosis" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Diseases" (2 trials), "Coronary Disease" (2 trials) and "Heart Diseases" (2 trials). Many other conditions were trialed in "Heart Health Institute" in a lesser frequency.

Most popular intervention types in "Heart Health Institute" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Simvastatin" (2 trials), "Azimilide Dihydrochloride" (1 trials), "Extended release niacin" (1 trials), "Placebo" (1 trials) and "SR34006 (idraparinux sodium) Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Health Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Heart Health Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Heart Health Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Health Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".